DE69934831D1 - MULTIPLEXES, FüR DIE ORALE VERBABREICHUNG GEEIGNETES MEDIKAMENTENABGABESYSTEM - Google Patents

MULTIPLEXES, FüR DIE ORALE VERBABREICHUNG GEEIGNETES MEDIKAMENTENABGABESYSTEM

Info

Publication number
DE69934831D1
DE69934831D1 DE69934831T DE69934831T DE69934831D1 DE 69934831 D1 DE69934831 D1 DE 69934831D1 DE 69934831 T DE69934831 T DE 69934831T DE 69934831 T DE69934831 T DE 69934831T DE 69934831 D1 DE69934831 D1 DE 69934831D1
Authority
DE
Germany
Prior art keywords
multiplexes
oral administration
medicament delivery
delivery suitable
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69934831T
Other languages
English (en)
Other versions
DE69934831T2 (de
Inventor
Richard Ting
Charles Hsiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Impax Pharmaceuticals Inc
Original Assignee
Impax Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Impax Pharmaceuticals Inc filed Critical Impax Pharmaceuticals Inc
Publication of DE69934831D1 publication Critical patent/DE69934831D1/de
Application granted granted Critical
Publication of DE69934831T2 publication Critical patent/DE69934831T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69934831T 1998-09-29 1999-09-13 MULTIPLEXES, FüR DIE ORALE VERBABREICHUNG GEEIGNETES MEDIKAMENTENABGABESYSTEM Expired - Lifetime DE69934831T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US164642 1998-09-29
US09/164,642 US6602521B1 (en) 1998-09-29 1998-09-29 Multiplex drug delivery system suitable for oral administration
PCT/US1999/020807 WO2000018447A2 (en) 1998-09-29 1999-09-13 Multiplex drug delivery system suitable for oral administration

Publications (2)

Publication Number Publication Date
DE69934831D1 true DE69934831D1 (de) 2007-02-22
DE69934831T2 DE69934831T2 (de) 2007-08-16

Family

ID=22595418

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934831T Expired - Lifetime DE69934831T2 (de) 1998-09-29 1999-09-13 MULTIPLEXES, FüR DIE ORALE VERBABREICHUNG GEEIGNETES MEDIKAMENTENABGABESYSTEM

Country Status (7)

Country Link
US (2) US6602521B1 (de)
EP (1) EP1416920B1 (de)
AU (1) AU6141199A (de)
DE (1) DE69934831T2 (de)
ES (1) ES2278455T3 (de)
TW (1) TWI228997B (de)
WO (1) WO2000018447A2 (de)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6837696B2 (en) 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
BR0212950A (pt) 2001-09-28 2004-10-26 Mcneil Ppc Inc Formas de dosagens compósitas tendo uma porção inserida
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
WO2003030823A2 (en) * 2001-10-05 2003-04-17 Combinatorx, Incorporated Combinations for the treatment of immunoinflammatory disorders
HUP0402611A2 (hu) * 2001-10-08 2005-07-28 Sun Pharmaceutical Industries Limited Görcsoldó hatóanyag szakaszos leadására szolgáló rendszer
WO2003051339A1 (fr) * 2001-12-19 2003-06-26 Sanwa Kagaku Kenkyusho Co.,Ltd Produit façonne du type a liberation controlee
RU2005108609A (ru) * 2002-09-28 2006-03-10 МакНЕЙЛ-ППС, ИНК. (US) Лекарственные формы с модифицированным высвобождением, имеющие два ядра и отверстие
DE60335270D1 (de) * 2002-09-28 2011-01-20 Mcneil Ppc Inc Darreichungsformen zur verzögerten freisetzung mit zwei kernen und einer öffnung
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US7988993B2 (en) 2002-12-09 2011-08-02 Andrx Pharmaceuticals, Inc. Oral controlled release dosage form
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
KR101192722B1 (ko) 2003-04-24 2012-10-18 자고텍 아게 정해진 핵 위치를 가지는 서방성 정제
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
US9492541B2 (en) * 2004-09-14 2016-11-15 Sovereign Pharmaceuticals, Llc Phenylepherine containing dosage form
EA200601597A1 (ru) * 2004-04-01 2007-04-27 Тева Фармасьютикал Индастриес Лтд. Композиции 6-меркаптопурина задержанного выделения
US8188067B2 (en) 2004-04-01 2012-05-29 Teva Pharmaceutical Industries Ltd. Formulations of 6-mercaptopurine
SE0401031D0 (sv) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
AU2005245028B2 (en) 2004-05-21 2010-12-09 Accu-Break Technologies, Inc. Pharmaceutical tablets having a relatively inactive segment
WO2005120432A1 (en) * 2004-06-07 2005-12-22 Duramed Pharmaceuticals, Inc. Dispenser for progestin used for acute and maintenance treatment of dub
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ728442A (en) 2004-10-21 2018-05-25 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US8383159B2 (en) 2004-10-27 2013-02-26 Mcneil-Ppc, Inc. Dosage forms having a microreliefed surface and methods and apparatus for their production
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
EP3205337A1 (de) * 2005-08-18 2017-08-16 Teijin Pharma Limited Formulierung, die eine genaue doseneinteilung aufweist
US8394812B2 (en) 2005-08-24 2013-03-12 Penwest Pharmaceuticals Co. Sustained release formulations of nalbuphine
HUE053838T2 (hu) * 2005-08-24 2021-07-28 Endo Pharmaceuticals Inc Nyújtott felszabadulású nabulfin-készítmények
CN103211779B (zh) * 2006-01-27 2016-03-16 阿代尔制药股份有限公司 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送***
CA2640382C (en) * 2006-01-27 2015-12-29 Eurand, Inc Drug delivery systems comprising weakly basic drugs and organic acids
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
WO2007139753A2 (en) * 2006-05-22 2007-12-06 Combinatorx, Incorporated Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
RU2450803C2 (ru) * 2006-06-01 2012-05-20 Шеринг Корпорейшн Фармацевтические композиции для пролонгированного высвобождения фенилэфрина
EP2366381A1 (de) * 2006-06-01 2011-09-21 MSD Consumer Care, Inc. Pharmazeutische Phenylephrin-Formulierungen und Zusammensetzungen zur Absorption im Darm
RU2008151945A (ru) * 2006-06-01 2010-07-20 Шеринг Корпорейшн (US) Лекарственные формы с пульсирующим высвобождением и фармацевтические композиции фенилэфрина
US20100239668A1 (en) * 2006-06-19 2010-09-23 Kaplan Allan S Segmented pharmaceutical dosage forms
SI2049123T2 (sl) 2006-08-03 2016-10-28 Horizon Pharma Ag Zdravljenje revmatoznih bolezni z zadržanim sproščanjem glukokortikoida
US20080075766A1 (en) * 2006-09-25 2008-03-27 Shun-Por Li Multi-core dosage form having transparent outer coating
BRPI0812784A2 (pt) * 2007-06-01 2014-12-02 Schering Plough Healthcare Composição farmacêutica compreendendo um substrato e um revestimento contendo um ingrediente ativo e polivinilálcool
MX2010001071A (es) * 2007-07-27 2010-03-09 Depomed Inc Formas de dosificacion retentivas gastricas pulsatiles.
CA2737131A1 (en) * 2007-09-19 2009-03-26 Zalicus Inc. Therapeutic regimens for the treatment of immunoinflammatory disorders
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
CA2709561A1 (en) * 2007-12-17 2009-06-25 Combinatorx, Incorporated Therapeutic regimens for the treatment of immunoinflammatory disorders
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
US20090263482A1 (en) * 2008-04-18 2009-10-22 Vered Rosenberger Treatment of inflammatory bowel disease with 6-mercaptopurine
WO2010014502A1 (en) * 2008-07-31 2010-02-04 Aptapharma, Inc. Functionally coated breakable tablets
CN102202656A (zh) * 2008-08-15 2011-09-28 蒂宝制药公司 治疗和预防cns障碍的胃滞留药用组合物
CA2749646A1 (en) * 2009-01-26 2010-07-29 Nitec Pharma Ag Delayed-release glucocorticoid treatment of asthma
NZ582836A (en) * 2009-01-30 2011-06-30 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
WO2011005686A1 (en) * 2009-07-06 2011-01-13 Aptapharma, Inc. Self-breaking tablets
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
US20110280936A1 (en) * 2010-05-17 2011-11-17 Aptapharma, Inc. Self Breaking Tablets
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US8911780B2 (en) * 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
WO2014175917A1 (en) 2013-04-23 2014-10-30 Zx Pharma, Llc Multiparticulate-menthol formulations and related methods
US10098845B2 (en) 2013-10-07 2018-10-16 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
BR112017027688A2 (pt) 2015-06-22 2018-09-04 Lipocine Inc Composições orais que contêm éster de 17- hidroxiprogesterona e métodos relacionados
EP3362053A4 (de) 2015-10-16 2019-04-17 Hadasit Medical Research Services and Development Ltd. Behandlung von nicht alkoholbedingter fettleber oder nicht alkoholbedingter steatohepatitis mit 6-mercaptopurin mit verzögerter freisetzung
CN108968976B (zh) 2017-05-31 2022-09-13 心脏起搏器股份公司 具有化学传感器的植入式医疗设备
US12004853B2 (en) 2017-07-26 2024-06-11 Cardiac Pacemakers, Inc. Systems and methods for disambiguation of posture
CN109381195B (zh) 2017-08-10 2023-01-10 心脏起搏器股份公司 包括电解质传感器融合的***和方法
CN109419515B (zh) * 2017-08-23 2023-03-24 心脏起搏器股份公司 具有分级激活的可植入化学传感器
CN109864746B (zh) 2017-12-01 2023-09-29 心脏起搏器股份公司 用于医学装置的多模式分析物传感器
CN109864747B (zh) 2017-12-05 2023-08-25 心脏起搏器股份公司 多模式分析物传感器光电子接口
US20210378968A1 (en) * 2020-05-28 2021-12-09 Johnson & Johnson Consumer Inc. Multi-cavity customizable dosage forms
US11071739B1 (en) 2020-09-29 2021-07-27 Genus Lifesciences Inc. Oral liquid compositions including chlorpromazine
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3336200A (en) * 1963-05-28 1967-08-15 Warner Lambert Pharmaceutical Tablet structure
FR1603314A (en) * 1965-02-23 1971-04-05 Pharmaceutical tablets - having a core and a matrix material
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4894240A (en) 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
FR2585948B1 (fr) 1985-08-06 1988-12-16 Pf Medicament Procede de fabrication de comprimes d'indometacine
ATE107857T1 (de) * 1986-06-10 1994-07-15 Euro Celtique Sa Zusammensetzung mit kontrollierter freisetzung von dihydrocodein.
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5017381A (en) * 1990-05-02 1991-05-21 Alza Corporation Multi-unit pulsatile delivery system
US5213738A (en) * 1990-05-15 1993-05-25 L. Perrigo Company Method for making a capsule-shaped tablet
US5286497A (en) 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
ES2073301T3 (es) 1991-05-20 1995-08-01 Marion Laboratories Inc Composicion multi-capa de liberacion controlada.
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
EP0546593B1 (de) * 1991-10-30 1997-09-03 Glaxo Group Limited Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5475577A (en) * 1992-07-07 1995-12-12 Donnelly Corporation Accessory attachment plate for vehicle panels
DE4313726A1 (de) * 1993-04-27 1994-11-03 Byk Nederland Bv Feste Darreichungsform
US5500227A (en) * 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
US5395626A (en) 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
IT1274879B (it) * 1994-08-03 1997-07-25 Saitec Srl Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same

Also Published As

Publication number Publication date
TWI228997B (en) 2005-03-11
ES2278455T3 (es) 2007-08-01
AU6141199A (en) 2000-04-17
EP1416920A2 (de) 2004-05-12
DE69934831T2 (de) 2007-08-16
WO2000018447A3 (en) 2004-02-19
US20030203028A1 (en) 2003-10-30
EP1416920A4 (de) 2004-05-12
US6602521B1 (en) 2003-08-05
WO2000018447A2 (en) 2000-04-06
EP1416920B1 (de) 2007-01-10

Similar Documents

Publication Publication Date Title
DE69934831D1 (de) MULTIPLEXES, FüR DIE ORALE VERBABREICHUNG GEEIGNETES MEDIKAMENTENABGABESYSTEM
AU3218299A (en) Press coated, pulsatile drug delivery system suitable for oral administration
ZA200107123B (en) Oral drug delivery system.
DE69923076D1 (de) Transthorakale arzneimittelabgabevorrichtung
HK1036230A1 (en) Drug delivery devices.
DZ1876A1 (fr) Médicaments pour administration orale.
AU7333601A (en) Drug delivery management system
HK1034898A1 (en) Topical compositions for nsai drug delivery.
HK1048427A1 (en) Drug delivery device.
DE50012448D1 (de) Retardierte, orale, pharmazeutische darreichnungsformen mit tramadol
HK1049438A1 (en) Sub-tenon drug delivery.
EP1091732A4 (de) Arzneistoffverabreichungssystem mit brauseaktivität zur oralen verabreichung
DE60019949D1 (de) Arzneimittel enthaltendes system zur oralen abgabevorrichtung
IL174396A0 (en) Oral drug delivery system
IL169083A (en) Medication administration system
HRPK20010706B1 (en) Tolperison-containing, pharmaceutical preparation for oral administration
ZA200308221B (en) Pharmaceutical compositions for oral and topical administration.
EE05415B1 (et) Ravimi manustamise vahend, eriti androgeenide manustamiseks
ATE348599T1 (de) Pharmazeutische dronedaron-zusammensetzung für die parenterale verabreichung
DE69736406D1 (de) Feste arzneizubereitung für die mundhygiene
AU2001258443A1 (en) Drug delivery device, especially for the delivery of gestodene
AU2367900A (en) Chewable drug delivery system
DE60331041D1 (de) Orale dosierform für die kontrollierte arzneimittelfreisetzung
ZA200409726B (en) Monocompartment osmotic controlled drug delivery system.
DE60016530D1 (de) Verabreichungsvorrichtung für Medikamentenlösungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition